Aidea Pharma(SH:688488) Zheng Quan Zhi Xing·2025-06-27 16:49Core Viewpoint - The company, Jiangsu Aidi Pharmaceutical Co., Ltd., has proposed a stock option incentive plan aimed at attracting and retaining talent, aligning the interests of shareholders, the company, and its core team for long-term development [6][7]. Summary by Sections Incentive Plan Overview - The incentive plan involves granting 11.375 million stock options, representing approximately 2.703% of the company's total share capital of 420,782,808 shares [2][11]. - The initial grant consists of 9.1 million options, accounting for 2.163% of the total share capital, while 2.275 million options are reserved [2][11]. Stock Option Details - The exercise price for the stock options is set at 13.01 yuan per share [4][17]. - The plan allows for adjustments to the number of options or exercise price in case of capital increases, stock dividends, or other corporate actions [3][27]. Eligible Participants - A total of 45 individuals will receive the initial stock options, representing 6.392% of the company's projected employee count of 704 by the end of 2024 [3][9]. - The plan excludes independent directors and supervisors from participation [4][10]. Plan Duration and Conditions - The incentive plan is valid for a maximum of 48 months from the date of the first grant [6][12]. - The plan includes specific performance targets for both company-level and individual-level assessments to determine the eligibility for exercising options [20][18]. Management and Approval Process - The shareholders' meeting is the highest authority for approving the plan, while the board of directors is responsible for its execution [7][21]. - The plan must be publicly disclosed and approved by shareholders, requiring a two-thirds majority vote [22][23]. Performance Assessment - The performance assessment for the company includes revenue and net profit targets for the years 2025 and 2026, with specific thresholds for option exercise eligibility [20][18]. - Individual performance will also be evaluated, impacting the number of options that can be exercised [19][20]. Adjustments and Compliance - The plan includes provisions for adjusting stock options and exercise prices in response to corporate actions such as stock splits or dividends [27][26]. - The company commits to not providing financial assistance for exercising options, ensuring compliance with relevant laws and regulations [10][4].